Skip to main content
COMPASS Pathways plc logo

COMPASS Pathways plc — Investor Relations & Filings

Ticker · CMPS ISIN · US20451W1018 LEI · 213800N7CUZIC6QSTZ31 US Manufacturing
Filings indexed 317 across all filing types
Latest filing 2025-07-30 Director's Dealing
Country GB United Kingdom
Listing US CMPS

About COMPASS Pathways plc

https://compasspathways.com/

COMPASS Pathways plc is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is developing its investigational COMP360 psilocybin treatment for difficult-to-treat mental health conditions. Its research and clinical trials focus on applications for treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD), and anorexia nervosa.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2025-07-30 English
8-K
Regulatory Filings
2025-07-29 English
8-K
Regulatory Filings
2025-06-23 English
FORM 4
Director's Dealing
2025-06-13 English
FORM 4
Director's Dealing
2025-06-13 English
FORM 4
Director's Dealing
2025-06-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.